Nuvectis Pharma Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVCT is expected to report earnings to fall 193.22% to -25 cents per share on August 06
Q2'25
Est.
$-0.25
Q1'25
Beat
by $0.53
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.26
The last earnings report on May 06 showed earnings per share of 27 cents, beating the estimate of -25 cents. With 52.06K shares outstanding, the current market capitalization sits at 187.21M.